202 related articles for article (PubMed ID: 25510249)
1. Activation of prostaglandin E2-EP4 signaling reduces chemokine production in adipose tissue.
Tang EH; Cai Y; Wong CK; Rocha VZ; Sukhova GK; Shimizu K; Xuan G; Vanhoutte PM; Libby P; Xu A
J Lipid Res; 2015 Feb; 56(2):358-68. PubMed ID: 25510249
[TBL] [Abstract][Full Text] [Related]
2. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
3. The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity.
Yasui M; Tamura Y; Minami M; Higuchi S; Fujikawa R; Ikedo T; Nagata M; Arai H; Murayama T; Yokode M
PLoS One; 2015; 10(8):e0136304. PubMed ID: 26308623
[TBL] [Abstract][Full Text] [Related]
4. Prostaglandin E
Bryson TD; Ross J; Peterson E; Harding P
Prostaglandins Other Lipid Mediat; 2019 Oct; 144():106349. PubMed ID: 31229524
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor.
Takayama K; García-Cardena G; Sukhova GK; Comander J; Gimbrone MA; Libby P
J Biol Chem; 2002 Nov; 277(46):44147-54. PubMed ID: 12215436
[TBL] [Abstract][Full Text] [Related]
6. EP4 receptor promotes invadopodia and invasion in human breast cancer.
Tönisen F; Perrin L; Bayarmagnai B; van den Dries K; Cambi A; Gligorijevic B
Eur J Cell Biol; 2017 Mar; 96(2):218-226. PubMed ID: 28094049
[TBL] [Abstract][Full Text] [Related]
7. Opposing effects of prostaglandin E
Carboneau BA; Allan JA; Townsend SE; Kimple ME; Breyer RM; Gannon M
Mol Metab; 2017 Jun; 6(6):548-559. PubMed ID: 28580285
[TBL] [Abstract][Full Text] [Related]
8. Generation of ROS by CAY10598 leads to inactivation of STAT3 signaling and induction of apoptosis in human colon cancer HCT116 cells.
Chae IG; Kim DH; Kundu J; Jeong CH; Kundu JK; Chun KS
Free Radic Res; 2014 Nov; 48(11):1311-21. PubMed ID: 25096910
[TBL] [Abstract][Full Text] [Related]
9. EP2 and EP4 receptors mediate PGE2 induced relaxation in murine colonic circular muscle: pharmacological characterization.
Martinez-Cutillas M; Mañé N; Gallego D; Jimenez M; Martin MT
Pharmacol Res; 2014 Dec; 90():76-86. PubMed ID: 25461458
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
11. The EP1/EP3 receptor agonist 17-pt-PGE
Theiler A; Konya V; Pasterk L; Maric J; Bärnthaler T; Lanz I; Platzer W; Schuligoi R; Heinemann A
Vascul Pharmacol; 2016 Dec; 87():180-189. PubMed ID: 27664754
[TBL] [Abstract][Full Text] [Related]
12. Suppression of acute rejection by administration of prostaglandin E2 receptor subtype 4 agonist in rat organ transplantation models.
Okamoto T; Okamoto S; Fujimoto Y; Tabata Y; Uemoto S
J Surg Res; 2013 Aug; 183(2):852-9. PubMed ID: 23478083
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 Reduces Cardiac Contractility via EP3 Receptor.
Gu X; Xu J; Zhu L; Bryson T; Yang XP; Peterson E; Harding P
Circ Heart Fail; 2016 Aug; 9(8):. PubMed ID: 27502370
[TBL] [Abstract][Full Text] [Related]
14. The prostaglandin EP4 receptor is a master regulator of the expression of PGE
Kashmiry A; Tate R; Rotondo G; Davidson J; Rotondo D
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Oct; 1863(10):1297-1304. PubMed ID: 30053598
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E
Czigler A; Toth L; Szarka N; Szilágyi K; Kellermayer Z; Harci A; Vecsernyes M; Ungvari Z; Szolics A; Koller A; Buki A; Toth P
Prostaglandins Other Lipid Mediat; 2020 Feb; 146():106389. PubMed ID: 31689497
[TBL] [Abstract][Full Text] [Related]
16. Blockade of prostaglandin E
Aringer I; Artinger K; Kirsch AH; Schabhüttl C; Jandl K; Bärnthaler T; Mooslechner AA; Herzog SA; Uhlig M; Kirsch A; Frank S; Banas M; Pollheimer M; Eller P; Rosenkranz AR; Heinemann A; Eller K
Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1869-F1880. PubMed ID: 30332316
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E
Xie T; Zhang Z; Cui Y; Shu Y; Liu Y; Zou J; Wang M; Wang Y; Yang Q; Pan X; Cai J; Sun X; Yao Y; Wang X
Exp Eye Res; 2021 Apr; 205():108507. PubMed ID: 33609510
[TBL] [Abstract][Full Text] [Related]
18. PGE
Neuschäfer-Rube F; Pathe-Neuschäfer-Rube A; Hippenstiel S; Püschel GP
Cytokine; 2019 Jan; 113():105-116. PubMed ID: 29929938
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of EP4-selective agonist exacerbates albuminuria and fibrosis of the kidney in streptozotocin-induced diabetic mice through IL-6.
Mohamed R; Jayakumar C; Ramesh G
Lab Invest; 2013 Aug; 93(8):933-45. PubMed ID: 23817085
[TBL] [Abstract][Full Text] [Related]
20. Antagonist of prostaglandin E2 receptor 4 induces metabolic alterations in liver of mice.
Li N; Zhang L; An Y; Zhang L; Song Y; Wang Y; Tang H
J Proteome Res; 2015 Mar; 14(3):1566-73. PubMed ID: 25669961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
